definiens: means, on a country - by - country basis ( 1 ) [ * * * ] percent ( [ * * * ] % ) if, as of the effective date of termination, therehas not been a Drug Approval Application filed for a particular Reverted Royalty - Bearing Product in such country in theterminated Region ; ( 2 ) [ * * * ] percent ( [ * * * ] % ) if, as of the effective date of termination, there has been a Drug ApprovalApplication filed for a particular Reverted Royalty - Bearing Product in such country in the terminated Region ; and ( 3 ) [ * * * ] percent ( [ * * * ] % ) if, as of the effective date of termination, a Commercialization Regulatory Approval has been received for aparticular Reverted Royalty - Bearing Product or the First Commercial Sale of such Reverted Royalty - Bearing Product hasoccurred, in either case, in such country in the terminated Region